EC50 and IC50: difference explained simply
EC50 and IC50: the difference
EC50 and IC50 look similar but do not answer the same question. IC50 describes the concentration at which a measured signal or activity is inhibited by 50 %. EC50 describes the concentration at which 50 % of the maximally observable effect in the chosen assay is reached. A lower value therefore only means at first: the defined 50 % point is reached at a lower concentration. Whether a compound binds better, has the greater maximal effect, or is overall superior cannot be reliably inferred from EC50 or IC50 alone. Further terminology is compiled in the Research Glossary.
What the two metrics actually measure in a dose-response curve
The shared 50 % logic seems similar but refers to different reference points. For practical planning of dose series, the Peptide Dilution Calculator is suitable. Prepare stock solutions with precisely defined concentration safely using the Reconstitution Calculator.
| Metric | What the 50 % refer to | What a lower value means |
|---|---|---|
| EC50 | To 50 % of the maximally achievable effect in the chosen assay | The half-maximal effect is reached at a lower concentration; this is not direct evidence of higher binding affinity. |
| IC50 | To 50 % inhibition of a measured signal, enzyme, or process | The defined inhibition threshold is reached at a lower concentration; this by itself does not prove stronger binding. |
When EC50 and IC50 are not interchangeable
EC50 and IC50 can lie close together only when a system fully traverses the relevant measurement range, i.e., up to complete inhibition or a clear maximal effect. In practice, this is often not the case. A partial agonist can have a well-determinable EC50 value even though its maximal effect remains well below that of a full agonist. Conversely, an inhibitor may inhibit in a concentration-dependent manner but never fall below the 50 % threshold; then an IC50 value is not methodologically meaningful to report. For interpretation, the distinction between potency and efficacy is central: needing little concentration is not the same as having a large maximal effect. Practical steps before setting up dose series are summarized in the Guide to reconstituting lyophilized peptides.
Why low values do not prove pure affinity
EC50 and IC50 are functional metrics. They come from a biological or biochemical readout and not from a direct measurement of binding at equilibrium. A low EC50 can be favored by good cell uptake, signal amplification, or a particularly sensitive model system. A low IC50 can also depend on substrate conditions and the assay window. If actual binding strength is sought, Kd or Ki answer a different question than EC50 or IC50. Therefore, comparisons are only reliable when assay type, endpoint, target system, and analysis conditions are sufficiently similar.
Which experimental conditions shift EC50 and IC50 values
Even small changes in the experimental setup can noticeably change the reported 50 % value. This also includes half-life & experimental design.
- Mechanism of inhibition and substrate concentration strongly influence IC50 in particular. The same inhibitor can appear weaker or stronger depending on the setup.
- Curve model, fit bounds, and normalization shift the point reported as 50 %. Relative and absolute analysis do not always give the same impression.
- Controls and signal range help determine where top and bottom levels lie and how cleanly the halfway mark can be calculated.
- In tight-binding situations or at high target concentration, apparent inhibitory potency can be distorted.
- Values from enzyme, cell, and in vivo models are not directly equivalent, because transport, distribution, and system response introduce additional effects.
How we contextualize EC50 and IC50 in research
At 24Peptides we deliberately separate material quality from biological potency. Our COA and quality content are based on analytical data such as HPLC, LC-MS, and contamination checks. Every lot is independently tested, including identity, purity, endotoxins, bioburden, and heavy metals, and documented per lot. Such evidence addresses questions of identity, purity, and burden. EC50 and IC50 values, by contrast, describe assay-dependent effects and are only meaningful together with the model, control system, and readout. For research peptides, these are two different but complementary layers of the same research work.
Terms that often appear alongside in studies: Kd, Ki, ED50, and LD50
Before numbers are compared, it should always be clear whether a study measures binding, inhibition, effect, or administered dose.
| Term | What is measured | Typical context |
|---|---|---|
| Kd | Equilibrium affinity between ligand and target | Binding assays; answers a different question than EC50 or IC50 |
| Ki | Inhibition constant for the inhibition relationship in the model | Enzymology and inhibition analysis; not identical to IC50 |
| EC50 | Concentration for 50 % of the maximally observable effect | Functional in vitro assays |
| IC50 | Concentration for 50 % inhibition of a measured signal | Functional inhibition assays |
| ED50 | Dose for 50 % of a defined effect | Dose-related, mostly in vivo-oriented contexts |
| LD50 | Dose with a lethal endpoint in 50 % of cases | Toxicological in vivo contexts; do not confuse with concentration-based in vitro values |
